Director

Youssef Bennani brings a wealth of experience from project inception to clinical work, technology transfer, in-and-out licensing transactions with academic and corporate partners R&D units. His work has led to over twenty preclinical and clinical-stage NMEs, out-licensed partnerships; as well as contributions to approved medicines.

 

Youssef has over 25 years' experience in pharmaceutical R&D leadership and management. He previously was Chairman of the Board of Domain Therapeutics; and an independent Board Director at Bellus Health until its successful acquisition by GSK. He also was a founding CEO at Find Therapeutics. Previously, he served as Site Head and Vice President of R&D at Vertex Pharmaceuticals Canada Inc. He has also held various positions of increasing responsibility in pharmaceutical R&D at Ligand Pharmaceuticals, Abbott Laboratories (now AbbVie) and Athersys. His experience spans multiple therapeutic areas including oncology, neurology, infection, inflammation, rare and renal diseases.

 

Youssef received his Ph.D. in chemistry from the Université de Montréal.